2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Renal Disease: new trials by email Literature Review of Renal Disease trials Research Report on Renal Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases AntiSARS-CoV-2 Serum, Placebo - Immunosuppression, Cancer | Phase 1 / Phase 2 | Unknown | Butantan Institute | 618 | 2021-05-01 | 2021-04-08 |
| An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients Oral Multivitamin - Hyperphosphatemia, Inflammation | Phase 2 | Unknown | Nephrian | 25 | 2009-01-01 | 2009-02-03 |
Kidney Diseases (2) · COVID-19 (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Hyperphosphatemia (1) · Inflammation (1) · Kidney Failure, Chronic (1) · Neoplasms (1) · Pulmonary Disease, Chronic Obstructive (1)
Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1)
Geritol (1)
Butantan Institute (1) · Nephrian (1)
Brazil (1) · United States (1)
Ray Chow, PhD (1) · Ricardo Palacios, MD, PhD (1)